Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19539498 | 0.90 | TLR7 (0.66) | TLR7 | |
| SCHEMBL3921515 | 0.89 | TLR7 (0.59) | TLR7NUDT1 | |
| SCHEMBL4423900 | 0.88 | TLR7 (0.57) | TLR7NUDT1 | |
| SCHEMBL17154083 | 0.88 | TLR7 (0.61) | TLR7NUDT1 | |
| SCHEMBL16481784 | 0.86 | TLR7 (0.61) | TLR7NUDT1 | |
| SCHEMBL19633673 | 0.85 | TLR7 (0.48) | TLR7NUDT1 | |
| SCHEMBL7205658 | 0.85 | TLR7 (0.60) | TLR7NUDT1 | |
| SCHEMBL509587 | 0.84 | TLR7 (0.74) | TLR7NUDT1 | |
| SCHEMBL19539457 | 0.84 | TLR7 (0.57) | TLR7NUDT1 | |
| SCHEMBL21076832 | 0.83 | YTHDC1 (0.50) | TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021110120-A1 | ANTI-TUMOR VACCINE MOLECULE, PREPARATION METHOD THEREFOR AND USE THEREOF | 华中师范大学 | 2021-06-10 | — | — | WO | disclosed |
| US-10703755-B2 | Substituted purine derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2020-07-07 | — | — | US | disclosed |
| US-20190169191-A1 | SUBSTITUTED PURINE DERIVATIVE | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10703755-B2 | Substituted purine derivative | TLR7, TLR9, TLR1 | TLR7 1/4885NUDT1 16/4885 |
| US-20190169191-A1 | SUBSTITUTED PURINE DERIVATIVE | TLR7, TLR9, TLR1 | TLR7 1/4885NUDT1 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.